Connect your AI

Amphastar Pharmaceuticals AMPH Earnings yield

Earnings yield at other companies

PfizerPFE

6.8%—

Halozyme TherapeuticsHALO

6.9%+1.5pp

ViatrisVTRS

-1.9%-0.9pp

Opko HealthOPK

-24.6%-29.5pp

AptarGroupATR

4.8%+1.0pp

ARS Pharmaceuticals, Inc.SPRY

-24.8%-26.2pp

Other financials

Income statement

Revenue$171.2M+0.4%

Gross profit$70.3M-17.5%

Operating income$13.6M-63.5%

Net income$6.4M-74.6%

EPS (diluted)$0.14-72.5%

Balance sheet

Cash & equivalents$170.9M-6.5%

Total debt$686.6M+5.2%

Total equity$445.5M—

Total assets$1.6B+1.3%

Cash flow

Operating cash flow$47.8M+36.4%

CapEx$9.5M-11.1%

Free cash flow$38.3M+57.2%

Valuation

Market cap$926.83M-19.9%

Enterprise value$1.44B-11.4%

P/E11.7×+3.5×

P/S1.3×-0.3×

Profitability

Gross margin47.3%-3.2pp

Operating margin16.2%-10.4pp

Net margin11%-8.4pp

FCF margin18.8%-1.8pp

Returns & leverage

Return on equity14.7%—

Debt / equity0.2×—

Current ratio3.9×+0.9×

Where this comes from

Calculated from Amphastar Pharmaceuticals’s reported figures.

net income/market cap=8.9%

Based on trailing twelve months.

The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amphastar Pharmaceuticals's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Amphastar Pharmaceuticals's earnings yield?: Amphastar Pharmaceuticals (AMPH) reported earnings yield of 8.9% in Q1 2026.
How has Amphastar Pharmaceuticals's earnings yield changed year-over-year?: Amphastar Pharmaceuticals's earnings yield decreased by 13.1% year-over-year, from 10.3% to 8.9%.
What is the long-term trend for Amphastar Pharmaceuticals's earnings yield?: Over 4 years (2021 to 2025), Amphastar Pharmaceuticals's earnings yield has grown at a 9.4% compound annual growth rate (CAGR), from 5.6% to 8%.
What does earnings yield mean?: Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.